-
公开(公告)号:EP1680114A2
公开(公告)日:2006-07-19
申请号:EP04796647.8
申请日:2004-10-27
申请人: AMGEN INC. , Japan Tobacco, Inc.
发明人: CARDOZO, Mario, G. , POWERS, Jay, P. , GOTO, Hiroyuki, c/o Japan Tobacco, Inc. , HARADA, Kazuhito, c/o Japan Tobacco, Inc. , IMAMURA, Katsuaki, c/o Japan Tobacco, Inc. , KAKUTANI, Makoto, c/o Japan Tobacco, Inc. , MATSUDA, Isamu, c/o Japan Tobacco, Inc. , OHE, Yasuhiro, c/o Japan Tobacco, Inc. , YATA, Shinji, c/o Japan Tobacco, Inc. , TU, Hua
IPC分类号: A61K31/445 , C07D401/04
CPC分类号: C07D401/12 , A61K31/18 , A61K31/4196 , A61K31/64 , A61K38/28 , A61K45/06 , C04B35/632 , C07D249/08 , C07D249/14 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/10 , C07D491/10
摘要: The present invention provides a triazole compound of the following formula: a prodrug thereof or a pharmaceutically acceptable salt thereof. The above-mentioned triazole compound is useful as a therapeutic drug for the treatment of diabetes, obesity or metabolic syndrome.